The technological revolution in the field of pharmaceutical circulation will upend tradition

To take stock of the complicated people and things in the field of medical circulation in our country is really a few joys and sorrows. "Two-vote system" "camp reform and increase", hospital drug sales, etc. , forcing pharmaceutical circulation enterprises to adjust their business strategy and marketing model. Coupled with The State Pharmaceutical Holdings, China Resources Pharmaceuticals, Shanghai Pharmaceutical Group, Kyushua Tong and other national pharmaceutical groups to attack the city, many small and medium-sized pharmaceutical distribution enterprises or was acquired, or difficult to survive, or self-exit.
erase the "small flaws" in theOver the past year, the field of pharmaceutical circulation has been very calm. The country lit up a road to rectify the market, regulate the market "gold medal", a large number of companies and individuals accustomed to ticketing, passing tickets feel the arrival of winter, comfortable for several years of good days finally came to an end. Millions of fines, time-limited rectifications, and the revocation of GSP certificates have given disorderly competitors a rallying point towards extinction. More pharmaceutical circulation enterprises strict self-discipline, and constantly regulate their own business model and promotional methods.
2017 is a year of continuous innovation for pharmaceutical distribution companies. Information technology, big data, supply chain and other Internet platforms quickly cut into the pharmaceutical industry, is changing the marketing model that has continued for many years, connecting upstream and downstream customers of the industrial chain and supply chain. Zero inventory, turnover rate, automatic replenishment, at the urging of the Internet system to speed up the operation of time and space, in-flight funds, reduce operating costs, some of the earliest docking information system of pharmaceutical circulation enterprises won the opportunity.
2017 is also a year of marketing model transformation, many pharmaceutical circulation enterprises (especially to do generic drug sales) set up their own sales control varieties team, from rough distribution and distribution to terminal customer service. Change ideas, catch varieties, build teams, cloth terminals, from porters to real salesmen, from simple distribution to academic promotion, the end customer firmly in control, improve the profitability of enterprises.
sales seems to have become a bright landscape in the circulation of medicine in the second half of last year. The most recent national drug exchange will become a feast to negotiate the control of the sale of varieties, the agents who came to attend the meeting not only have the main body of pharmaceutical companies, there are many varieties of natural persons, new special drugs have become the field of circulation incense. Manufacturers keep asking visitors, "Do you do control sales or do circulation?" "Most agents will say, "I'm in control of sales" and then tell the manufacturers how many end customers they have in their hands.
star point, 2017 pharmaceutical circulation in the field of innovative ideas, innovative models become the main theme, irregular people and things are only some small flaws in the course of market operation, is slowly being eliminated by the market.technological revolution to upendin 2018, the field of pharmaceutical circulation still challenges and opportunities coexist, market and benefit sharing. Whether it is state-owned enterprises or private enterprises shareholding system, we all want to develop, development is the hard truth. However, the change of concept and the innovation of model are still the main line in the field of pharmaceutical circulation in 2018. Running the horse circle, restructuring mergers and acquisitions, joint-stock system, grouping ... The big men in circulation will also play high in accordance with their layout and move forward.
small and medium-sized enterprises, which account for 80 per cent of the total, want to do it themselves, except for a significant proportion of those who are willing to be acquired and restructured for subjective and objective reasons. It is not easy to set their own base industry, after all, fall and climb for many years, accumulated a fairly wide range of quite perfect contacts and channel resources, but also with upstream manufacturers to establish a inextricably linked, with a certain variety of resources. They don't leave easily until they encounter something they can't resist. In the author's opinion, the company is not afraid of small, as long as it has its own varieties, has its own terminal network, has its own promotion team, has a courage to explore the spirit of daring to storm the formation, firm belief, do professional company, keep an eye on a piece of the terminal market to work hard, or can harvest fruitful results.
2018 is also a year of reshuffle in the field of medicine circulation, has been called "wolf is coming, wolf is coming", wolves will eventually come, strong Hengqiang. Although not weak meat, but the market itself is full of many uncertainties, competition is cruel, the survival of the fittest is the eternal law of market competition. Tenacious rise, and then create brilliant, that is not a word hanging on the mouth, the competition between enterprises, the fight is strength, capital, network, variety and information, intelligent.
will usher in a technological revolution in the entire field of pharmaceutical circulation, disrupting decades of operation. Internet, information technology, intelligent and comprehensive penetration into all levels of the field of pharmaceutical circulation, series of insaling, ordering, warehousing, supervision, shipping, settlement and other series of processes, so that from manufacturers to distributors distributors to end customers, product flow, product inventory is fully informatized, transparent, through the link between upstream and downstream customers of all chains. It will speed up the turnover of product inventory and operating capital, make the supply chain process more systematic and flat, so as to reduce the costs in the process of operation and improve the economic benefits of enterprises.
the rapid operation of informationization and intelligence in enterprises will promote the transformation of the whole field of pharmaceutical circulation, improve the concentration of the industry, large-scale, group-based, intelligent large companies to lead the trend. Information technology, intelligent construction needs strong back-office support, in the final analysis has gone beyond the scope of the concept, is high-end talent, abundant capital, mature technology to jointly build a platform to subvert the original industry model.
2018, the field of pharmaceutical circulation will present a situation in which the stars shine and shine on the one hand, and the trees fall on the other, quietly leaving the scene. The survival of the fittest, the development of the strong, this is the inevitable result of the operation of the market. Rui Xue Mega Year, sail for the New Year! (Medical Economics)